Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.21 is 121% below its 4-year average of -0.09, near the low end of its 4-year range (-0.21–-0.06).
140.55% below its 12-month average of -0.09.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-03-31): -0.38.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 11 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:45:16.563Z. Historical observations retain their original dates. Historical series through 2026-05-15.
EARNINGS PER SHARE (EPS)
-0.21
EARNINGS PER SHARE (EPS) AVG TTM
-0.09
EARNINGS PER SHARE (EPS) AVG 3Y
-0.10
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-140.55%
CURRENT VS 3Y AVG
-102.60%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.09
3Y Avg
-0.10
5Y Avg
N/A
Market Cap
$9.09M
Earnings Per Share (EPS)
-65.58
TTM Avg
-8524.08
3Y Avg
-26524.29
5Y Avg
-21051.80
Market Cap
$8.37M
Earnings Per Share (EPS)
-1.08
TTM Avg
-2.14
3Y Avg
-342.00
5Y Avg
-242.25
Market Cap
$9.42M
Earnings Per Share (EPS)
N/A
TTM Avg
-6.41
3Y Avg
-27.87
5Y Avg
-55.81
Market Cap
$7.77M
Earnings Per Share (EPS)
-104.00
TTM Avg
-164.88
3Y Avg
-121.81
5Y Avg
-116.67
Market Cap
$7.75M
Earnings Per Share (EPS)
-23.59
TTM Avg
-251.09
3Y Avg
-121778.80
5Y Avg
-249058.36
Market Cap
$9.79M
Earnings Per Share (EPS)
-2.52
TTM Avg
-2.51
3Y Avg
-3.38
5Y Avg
-3.13
Market Cap
$10.07M
Earnings Per Share (EPS)
-3.91
TTM Avg
-36.08
3Y Avg
-152.15
5Y Avg
-116.13
Market Cap
$10.27M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | -0.21 | -0.09 | -0.10 | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | -65.58 | -8524.08 | -26524.29 | -21051.80 |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | -1.08 | -2.14 | -342.00 | -242.25 |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A | -6.41 | -27.87 | -55.81 |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | -104.00 | -164.88 | -121.81 | -116.67 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | -23.59 | -251.09 | -121778.80 | -249058.36 |
| Ainos, Inc. (AIMD)vs › | $9.79M | -2.52 | -2.51 | -3.38 | -3.13 |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | -3.91 | -36.08 | -152.15 | -116.13 |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -0.73 | -0.46 | -0.46 | -0.46 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | -7.38 | -1.62 | -0.82 | -0.82 |
Trailing EPS (TTM)
$-0.21
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-06-30 | -0.09 |
| 2024-06-30 | -0.08 |
| 2023-06-30 | -0.11 |
| 2022-06-30 | -0.13 |
| 2021-06-30 | -0.06 |
